Your session is about to expire
← Back to Search
High-Intensity Interval Training for Respiratory Diseases
N/A
Recruiting
Led By William Cornwell, MD, MSCS
Research Sponsored by University of Colorado, Denver
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 1 hour
Awards & highlights
Study Summary
This trial will study veterans with new respiratory symptoms after deployment to learn if exercise can help improve their fitness and symptoms.
Who is the study for?
This trial is for veterans with new breathing difficulties after being deployed to Southwest Asia since September 2001. They must live close to Rocky Mountain Regional VA, be vaccinated against COVID-19, and able to do high-intensity exercise. Excluded are those with uncontrolled heart or lung diseases, severe obesity or underweight conditions, certain blood disorders like anemia, active smokers, and pregnant women.Check my eligibility
What is being tested?
The study tests if a 12-week program of high-intensity interval training (HIIT) on stationary bikes can improve fitness and respiratory symptoms in these veterans. It includes initial and follow-up tests for heart and lung function as well as questionnaires about their health status.See study design
What are the potential side effects?
While the trial does not involve medication that could cause side effects typically associated with drugs, HIIT may lead to muscle soreness, fatigue or exacerbation of underlying health issues due to intense physical activity.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 1 hour
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 1 hour
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Health-related quality of life by Short Form 36 (SF-36) questionnaire
Maximum oxygen consumption (VO2max)
Secondary outcome measures
Feasibility of exercise program, reported by participant and measured by responses to questionnaire
Left ventricular ejection fraction measured by transthoracic echocardiogram
Plasma acylcarnitine 10:0 measured by peripheral venous metabolomics (ultra-high performance liquid chromatography coupled to mass spectrometry)
+1 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: Veterans with respiratory symptomsExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Exercise training
2019
Completed Phase 1
~1110
Find a Location
Who is running the clinical trial?
University of Colorado, DenverLead Sponsor
1,738 Previous Clinical Trials
2,149,514 Total Patients Enrolled
VA Office of Research and DevelopmentFED
1,611 Previous Clinical Trials
3,305,272 Total Patients Enrolled
William Cornwell, MD, MSCSPrincipal InvestigatorUniversity of Colorado, Denver
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have lung problems or asthma linked to my service, or I get unusually out of breath with activity.I live within 90 miles of Rocky Mountain Regional VA and can attend in-person sessions.I started having new breathing problems during or after deployment.I do not have any uncontrolled heart or lung conditions.I get short of breath when I exert myself or exercise.I am fully vaccinated against COVID-19, including all eligible boosters.I am a woman and have gone through menopause.
Research Study Groups:
This trial has the following groups:- Group 1: Veterans with respiratory symptoms
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Does the protocol for this research include seniors?
"This study has a narrow age range of 18 to 55, while there are other trials catering specifically to those below the former or above the latter."
Answered by AI
Is my profile suitable for participating in this experimental program?
"To participate in this trial, applicants must meet a certain criteria: they must have had occupational exposure and be between 18 to 55 years of age. A total of 12 individuals may partake in the experiment."
Answered by AI
Are there any open slots for participants in this research project?
"According to clinicaltrials.gov, recruitment for this trial has been concluded; the study was initially posted on May 1st 2023 and last updated 5 days later. However, 93 other medical studies are currently recruiting patients."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger